Accounting

Apps

Architecture

Artificial Intelligence

Asset and Wealth Management

Biotechnology

Blockchain

Brokerage

Commerce and Retail

Consultancy

Consulting Services

Corporate Banking

Corporate Supplies and Printing

Data and Analytics

E-Commerce

FinTech

Foreign Exchange

Healthtech

Hedge Funds

Information Technology

InsurTech

Insurance

Internet Services

Investment Banking

Legal Services

Life Insurance

Medtech and Medical Devices

Mobile

Navigation and Mapping

Outsourcing

Pharmaceuticals and Life Sciences

Platforms

Privacy and Security

Private Banking

Private Equity

Real Estate

Recruiting and Employment Services

RegTech

Regulator

Retail Banking

Robotics

Software

Technology, Hardware and Equipment

Translation Services

PensionBee have announced plans for an initial public offering, and have said they will give its client base an opportunity to buy shares in the company. Hiring is expected to be ongoing as they complete their offering.

PensionBee announces plans for IPO

Michele F. Robertson has left Mallinckrodt Pharmaceuticals to join DBV Technologies as Chief Legal Officer. They previously served as Senior Counsel.

Mallinckrodt Pharmaceuticals loses Senior Counsel to DBV Technologies

Laura Kelly has left EMD Serono to join Monopar Therapeutics as Director of Clinical Operations. They previously served as Senior Manager, Clinical Site Lead.

EMD Serono loses Senior Manager, Clinical Site Lead to Monopar Therapeutics

Diabsolut have acquired Foundry52.com. Hiring is expected to support the acquisition and future growth strategies.

Diabsolut completes acquisition of Foundry52.com

Borrowell have raised $25m in new funding with which they have completed the acquisition of Refresh Financial. The funding will also be used to continue the strengthening of their services; hiring is anticipated to facilitate this.

Borrowell raises $25m in venture funding

Ensysce Biosciences have appointed David Humphrey Chief Financial Officer. They join the company from Senomyx, inc., where they served as Vice President and Chief Financial Officer.

Ensysce Biosciences appoints David Humphrey as Chief Financial Officer

Business News - Predictive Market Intelligence

Pick a Industry from the list below